Riskpilot← Back to searchSign inGet full accessLUNGEKLINIKKEN AS
ASActiveOrg 919159871Nedre Storgate 7, 3015 DrammenMedical specialists activities · NACE 8622Est. 20177 employees
Revenue 2025
NOK 18M
+6% vs 2024
EBITDA margin
49.9%
+4% vs 2024
Equity ratio
41.8%
Financial strength
Net profit 2025
NOK 7,1M
+9% vs 2024
| Revenue | NOK 18M | +6% |
| EBITDA | NOK 9M | +4% |
| Net profit | NOK 7,1M | +9% |
| Total assets | NOK 17M | +8% |
| Equity | NOK 7,1M | +9% |
| Employees | 7 | — |
Legal name
LUNGEKLINIKKEN AS
Org number
919159871
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
21. juni 2017
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Legevirksomhet, medisinske konsulenttjenester samt medisinsk forskning og utvikling og dermed forbundne oppgaver, kjøp, salg og drift av fast eiendom samt deltagelse i andre selskaper og alt hva herved er forbundet.
Address
Nedre Storgate 7, 3015 Drammen
Phone
+4732837085
Email
post@lungeklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 962 | 13 854 | 16 445 | 17 038 | 18 041 |
| Staff expenses | −1 835 | −2 559 | −4 557 | −6 228 | −6 680 |
| EBITDA | 6 278 | 8 334 | 10 243 | 8 625 | 9 003 |
| Depreciation & amort. | −709 | −548 | −376 | −257 | −249 |
| EBIT | 5 569 | 7 785 | 9 867 | 8 368 | 8 755 |
| Net financials | −192 | −121 | −222 | −39 | −41 |
| Profit before tax | 5 377 | 7 664 | 9 644 | 8 328 | 8 714 |
| Tax | 1 289 | 1 704 | 2 094 | 1 822 | 1 646 |
| Net profit | 4 088 | 5 960 | 7 550 | 6 507 | 7 068 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 352 | 15 117 | 16 817 | 15 679 | 17 001 |
| Equity | 756 | 5 016 | 7 666 | 6 537 | 7 105 |
| Long-term debt | 7 280 | 6 521 | 6 162 | 5 803 | −1 293 |
| Short-term debt | 5 316 | 3 579 | 2 988 | 2 959 | 3 158 |
| Total debt | 12 596 | 10 101 | 9 150 | 8 762 | 8 603 |
EBITDA margin
49.9%
This company
15.8%
Market median
+216% vs market
20212025
Equity ratio
41.8%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
99.5%
This company
18.4%
Market median
+441% vs market
20212025
Net profit margin
39.2%
This company
8.1%
Market median
+384% vs market
20212025
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
20212025
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Deputy Member | Deputy Member | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LUNGEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mai Thao Nguyen | Deputy Member | 0 companies |
| Duc Hoa Nguyen | Chairman | 0 companies |